We strive to improve our development pipelines by introducing many developmental and final products and discovering drugs in-house.
We strive to improve our development pipelines by introducing many developmental and final products and discovering drugs in-house.
Areas of disease*
Areas of disease*
・ Autoimmune diseases
・ Orthopedic diseases
・ Metabolic diseases
・ Autoimmune diseases
・ Orthopedic diseases
・ Metabolic diseases
*Including rare diseases
*Including rare diseases
Modality
Modality
・ Antibodies
・ Low molecular
・ Antibodies
・ Low molecular
Development phases
Development phases
・ Non-clinical products
(IND and those that follow)
・ Clinical products
(Page 1 to 3, approved and marketed products)
・ Non-clinical products
(IND and those that follow)
・ Clinical products
(Page 1 to 3, approved and marketed products)
Territory
Territory
・ Japan
・ Japan
Taisho Pharmaceutical seeks developmental and final products that fall under any of the above categories.
To inquire about a specific issue, contact us using the email form below or at taisho_rx_bdl@taisho.co.jp..
Taisho Pharmaceutical seeks developmental and final products that fall under any of the above categories.
To inquire about a specific issue, e-mail us using the button below.